Ads
related to: small cell lung cancer statistics- Overall Survival Data
Explore Study Results For A First-
Line Extensive-Stage SCLC Treatment
- SCLC Treatment
Learn About A First-Line
Therapy For Small Cell Lung Cancer.
- ES-SCLC Safety Info
View Safety & Tolerability Profile
For A Small Cell Lung Cancer Drug.
- See The OS Data
Discover OS Data For An
Extensive-Stage SCLC Treatment.
- Dosing & Administration
Discover Infusion Info For A Small
Cell Lung Cancer Medication.
- Resources & Support
Support Program, Financial Support,
& Downloadable Resources Available.
- Overall Survival Data
Search results
Results From The WOW.Com Content Network
Small-cell lung carcinoma can occur in combination with a wide variety of other histological variants of lung cancer, [14] including extremely complex malignant tissue admixtures. [ 15 ] [ 16 ] C-SCLC is the only currently recognized subtype of SCLC.
There are two main types of lung cancer, categorized by the size and appearance of the malignant cells seen by a histopathologist under a microscope: small cell lung cancer (SCLC; 15% of cases) and non-small-cell lung cancer (NSCLC; 85% of cases). [18] SCLC tumors are often found near the center of the lungs, in the major airways. [19]
Lung cancer is the overall leading cause of cancer deaths across the nation. The American Cancer Society estimates that about 226,000 new cases of lung cancer will be diagnosed in 2025, ...
Small cell lung cancer is often treated as a systematic disease due to its tendency for early dissemination, [4] thus, instead of the traditional TNM staging system, the Veterans' Administration Lung Study Group (VALSG) introduced a simplified 2-stage system in the 1950s to divide small cell lung cancer into limited stage and extensive stage. [7]
Combined small cell lung carcinoma (or c-SCLC) is a form of multiphasic lung cancer that is diagnosed by a pathologist when a malignant tumor, arising from transformed cells originating in lung tissue, contains a component of small cell lung carcinoma (SCLC) mixed with one or more components of any histological variant of non-small cell lung carcinoma (NSCLC) in any relative proportion.
Small cell lung cancer has a five-year survival rate of 4% according to Cancer Centers of America's Website. [5] The American Cancer Society reports 5-year relative survival rates of over 70% for women with stage 0-III breast cancer with a 5-year relative survival rate close to 100% for women with stage 0 or stage I breast cancer.
Ads
related to: small cell lung cancer statistics